These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19764841)

  • 21. Usability, participant acceptance, and safety of a prefilled insulin injection device in a 3-month observational survey in everyday clinical practice in Australia.
    Carter J; Beilin J; Morton A; De Luise M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1425-38. PubMed ID: 20144398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens.
    Clark PE; Valentine V; Bodie JN; Sarwat S
    Curr Med Res Opin; 2010 Jul; 26(7):1745-53. PubMed ID: 20482243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the dose accuracy of insulin pens.
    Hänel H; Weise A; Sun W; Pfützner JW; Thomé N; Pfützner A
    J Diabetes Sci Technol; 2008 May; 2(3):478-81. PubMed ID: 19885213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FlexPen for the delivery of insulin: accuracy, injection force and patient preference.
    Pfützner A
    Expert Rev Med Devices; 2009 Mar; 6(2):115-23. PubMed ID: 19298158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Pan-European and Canadian prospective survey to evaluate patient satisfaction with the SoloSTAR insulin injection device in type 1 and type 2 diabetes.
    Hancu N; Czupryniak L; Genestin E; Sourij H
    J Diabetes Sci Technol; 2011 Sep; 5(5):1224-34. PubMed ID: 22027323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long-acting versus short-acting insulins?
    Lefkowitz M
    J Diabetes Sci Technol; 2011 Jan; 5(1):136-49. PubMed ID: 21303636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens.
    Ignaut DA; Opincar MR; Clark PE; Palaisa MK; Lenox SM
    Curr Med Res Opin; 2009 Dec; 25(12):2829-33. PubMed ID: 19916727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient acceptance and issues of education of two durable insulin pen devices.
    Asakura T; Seino H; Jensen KH
    Diabetes Technol Ther; 2008 Aug; 10(4):299-304. PubMed ID: 18715204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injecting without pressing a button: An exploratory study of a shield-triggered injection mechanism.
    Zijlstra E; Coester HV; Heise T; Plum-Mörschel L; Rasmussen O; Rikte T; Pedersen LK; Qvist M; Sparre T
    Diabetes Obes Metab; 2018 May; 20(5):1140-1147. PubMed ID: 29369493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the FlexPen device.
    Forst T; Hohberg C; Schöndorf T; Borchert M; Forst S; Roth W; Dehos B; Pfützner A
    Diabetes Technol Ther; 2009 Feb; 11(2):87-92. PubMed ID: 19848574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study to examine the tolerability and device preference in type 1 diabetes of insulin aspart administered by InsuJet compared with subcutaneous injection.
    Reutens AT; Balkau B; Cohen N
    Diabetes Technol Ther; 2014 Apr; 16(4):235-40. PubMed ID: 24286115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of intuitiveness, ease of use, and preference in two insulin pens.
    Asakura T; Jensen KH
    J Diabetes Sci Technol; 2009 Mar; 3(2):312-9. PubMed ID: 20144362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injection force and dose accuracy of FlexTouch for the delivery of a new basal insulin.
    Götzche D; Rasmussen BØ; Pedersen MT; Sparre T; Bucher D; Niemeyer M
    Expert Opin Drug Deliv; 2013 Dec; 10(12):1613-9. PubMed ID: 24256325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An analysis of patient acceptance and safety of a prefilled insulin injection device.
    Kroon L
    J Diabetes Sci Technol; 2009 Nov; 3(6):1439-41. PubMed ID: 20144399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses.
    Oyer D; Narendran P; Qvist M; Niemeyer M; Nadeau DA
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1259-69. PubMed ID: 21905942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of a new disposable insulin pen and injection habits of diabetes patients in everyday clinical practice].
    Böhler S; Landgraf W; Schreiber SA
    MMW Fortschr Med; 2010 Jan; 151 Suppl 4():179-87. PubMed ID: 21595146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FlexPen: addressing issues of confidence and convenience in insulin delivery.
    Korytkowski M; Niskanen L; Asakura T
    Clin Ther; 2005; 27 Suppl B():S89-100. PubMed ID: 16519040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosing Accuracy of Two Disposable Insulin Pens According to New ISO 11608-1: 2012 Requirements.
    Abdel-Tawab M; Schmitz M; Kamlot S; Schubert-Zsilavecz M
    J Diabetes Sci Technol; 2015 Jul; 10(1):157-61. PubMed ID: 26187635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.